Dennis Gillings

Dr. Dennis B. Gillings is a Chief Executive Officer at PharmaBio Development, Inc. and a Non-Executive Chair & Founder at GHO Capital Partners LLP.
He is on the Board of Directors at Neusentis, Inc. and Southampton University Development Trust.
Dr. Gillings was previously employed as a Pro-Chancellor by The University of Southampton, a Lead Director by IQVIA RDS, Inc., a Class I Director by Quintiles Transnational Holdings, Inc., a Founding Chairman by Association of Clinical Research Organizations, a Co-Founder by IQVIA Holdings, Inc., a Consultant by National Cancer Institute, and a Professor by The University of North Carolina at Charlotte.
He also served on the board at The Life Sciences Foundation, XRpro Sciences, Inc., North Carolina Institute of Medicine, Triangle Pharmaceuticals, Inc., UNC Health Care System and United Way of Greater Los Angeles.
He received his doctorate degree from The University of Exeter.